CONMED (CNMD) PT Raised to $120 at Piper Jaffray
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $51.07 -0.6%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Piper Jaffray analyst Matt O'Brien raised the price target on CONMED (NASDAQ: CNMD) to $120.00 (from $110.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
- AAC Technologies Holdings Inc. (2018:HK) (AACAY) PT Raised to HK$55.50 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
